Pharmabiz1m
RNT Health Insights receives second US FDA breakthrough device designation for esophageal cancer detection tool
RNT Health Insights, a Chandigarh-based health-tech startup specializing in AI-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, has been granted ...
Pharmabiz14m
US FDA grants orphan drug designation to NMD Pharma’s NMD670 to treat patients with Charcot-Marie-tooth disease
US FDA grants orphan drug designation to NMD Pharma’s NMD670 to treat patients with Charcot-Marie-tooth disease: Aarhus, Denmark Tuesday, January 7, 2025, 16:00 Hrs [IST] NMD Ph ...
Pharmabiz1h
eMBR Genomics partners with Axio BioPharma to make MKLP1 Pro antibodies commercially available
MBR Genomics partners with Axio BioPharma to make MKLP1 Pro antibodies commercially available: Madison, Wisconsin Tuesday, January 7, 2025, 15:00 Hrs [IST] In a milestone for cel ...
Pharmabiz2h
Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints
Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints: Zug, Switzerland Tuesday, January 7, 202 ...
Pharmabiz4h
Biotech Showcase 2025 is set to convene in San Francisco for Biotech Investor Conference
Biotech Showcase 2025 is set to convene in San Francisco for Biotech Investor Conference: Our Bureau, Mumbai Tuesday, January 7, 2025, 12:00 Hrs [IST] Biotech Showcase 2025, an ex ...
Pharmabiz4h
Sun Pharma inaugurates Training-Cum-Production Centre to empower women in Jammu
Sun Pharma inaugurates Training-Cum-Production Centre to empower women in Jammu: Our Bureau, Mumbai Tuesday, January 7, 2025, 11:15 Hrs [IST] As a part of its CSR vision to bring ...
Pharmabiz4h
CRIUS Group adopts 100%AI-based project implementation
Our Bureau, Bengaluru Tuesday, January 7, 2025, 11:30 Hrs [IST] CRIUS Group has emerged as India’s first contract manufac ...
Pharmabiz4h
Claypond Capital appoints Dr Shravan Subramanyam to lead its medical technology platform
Claypond Capital appoints Dr Shravan Subramanyam to lead its medical technology platform: Our Bureau, Bengaluru Tuesday, January 7, 2025, 11:45 Hrs [IST] Claypond Capital, the fam ...
Pharmabiz5h
Santhera enters supply and distribution agreement with Clinigen Group for Agamree to treat patients with Duchenne muscular dystrophy
Pratteln, Switzerland Tuesday, January 7, 2025, 11:00 Hrs [IST] ...
Pharmabiz7h
Astellas Pharma’s Vyloy receives China NMPA approval for first-line treatment of advanced gastric or GEJ adenocarcinoma
Astellas Pharma’s Vyloy receives China NMPA approval for first-line treatment of advanced gastric or GEJ adenocarcinoma: Tokyo Tuesday, January 7, 2025, 09:00 Hrs [IST] Astellas ...
Pharmabiz6h
CHOP researchers develop new tool with potential to advance precision medicine treatment for cancer
CHOP researchers develop new tool with potential to advance precision medicine treatment for cancer: Philadelphia, Pennsylvania Tuesday, January 7, 2025, 10:00 Hrs [IST] Researche ...
Pharmabiz8h
Indian pharma notes revised Schedule M extension signals key step to avoid closure of units
Indian pharma notes revised Schedule M extension signals key step to avoid closure of units: Nandita Vijayasimha, Bengaluru Tuesday, January 7, 2025, 08:00 Hrs [IST] Indian pharma ...